NYSE:GSK

GSK - GSK Price Target & Analyst Ratings

$35.04

+0.66 (+1.92%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $34.68
▼
$35.14
50-Day Range: $33.50
▼
$36.43
52-Week Range: $28.47
▼
$46.97

Volume: 3.03 million shs
Average Volume: 3.73 million shs
Market Capitalization: $75.53 billion

P/E Ratio: 4.08
Dividend Yield: 3.80%
Price Target: N/A

Institutional Ownership

GSK Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

N/A

Type	Current 3/28/22 to 3/28/23	1 Month Ago 2/26/22 to 2/26/23	3 Months Ago 12/28/21 to 12/28/22	1 Year Ago 3/28/21 to 3/28/22
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	4 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Predicted Upside	N/A	N/A	N/A	N/A

Get GSK Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GSK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GSK Stock vs. The Competition

Type	GSK	Medical Companies	S&P 500
Consensus Rating Score	2.09	2.64	2.47
Consensus Rating	Hold	Buy	Hold
Predicted Upside		1,466.30% Upside	22.13% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target
3/17/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
2/26/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Buy
2/10/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		GBX 1,580 ➝ GBX 1,730
2/2/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		GBX 1,350 ➝ GBX 1,400
12/8/2022	AlphaValue Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Buy
12/5/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform

12/2/2022	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		GBX 1,975 ➝ GBX 1,550
11/30/2022	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		GBX 1,650 ➝ GBX 1,535
11/11/2022	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Sell
10/14/2022	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		GBX 1,800 ➝ GBX 1,450
9/29/2022	Oddo Bhf Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform
9/15/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Neutral
9/8/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
2/28/2022	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
2/11/2022	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Elmar Kraus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
6/2/2021	Baader Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy
3/29/2021	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Porges Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
11/2/2020	Liberum Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
9/18/2020	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy

(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

GSK Price Target - Frequently Asked Questions

What is GSK's consensus rating?: According to the issued ratings of 11 analysts in the last year, the consensus rating for GSK stock is Hold based on the current 3 sell ratings, 4 hold ratings and 4 buy ratings for GSKthe . Learn more on GSK's analyst rating history.
Do Wall Street analysts like GSK more than its competitors?: Analysts like GSK less than other Medical companies. The consensus rating for GSK is Hold while the average consensus rating for medical companies is Buy. Learn more on how GSK compares to other companies.
Is GSK being upgraded or downgraded by Wall Street analysts?: Over the previous 90 days, GSK's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover GSK?: GSK has been rated by Berenberg Bank, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., and The Goldman Sachs Group in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NYSE:GSK) was last updated on 3/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial